Search

everythinglearnresearchcommunity

for

Search:↓

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

A patient developed a blister at the injection site after hepatitis C treatment.

Removing the liver tumor improved the patient's skin condition and hair growth.

Higher PHGDH levels cause unusual melanin buildup in hair follicles.

Pexidartinib often causes liver issues and fatigue, especially in women.

CTHRC1 is essential for healing and preventing heart rupture after a heart attack.

Skin reactions to drugs are most often rashes caused by antibiotics, with nevirapine being the most common culprit; knowing these patterns can improve treatment and outcomes.

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

A kidney transplant patient developed pink skin bumps with spiny centers on her face and limbs.

Ulcerative sarcoidosis in body folds is rare and improved with prednisone and hydroxychloroquine.

Managing multiple autoimmune diseases in one patient is very challenging.

A new mutation in the KRT86 gene causes a hair disorder with variable expression.

A woman developed a severe skin reaction called toxic epidermal necrolysis after taking the antibiotic cephalexin.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

A 66-year-old woman with skin lesions and other symptoms improved after treatment for porphyria cutanea tarda.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Vitamin D Dependent Rickets Type-2A can cause complete hair loss and bone growth issues in infants.

Alopecia areata may be linked to kidney issues, but more research is needed.

A rare genetic disease causes rickets and often hair loss in young children, which can improve with specific treatments.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

The newborn's skin condition improved over time, leaving only lighter skin patches.

High doses of dihydroartemisinin caused reversible liver toxicity in rats, with females more affected than males.

Ruxolitinib cream may help treat severe hair loss in children.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

A new syndrome, Teelwani Syndrome, combines features of two rare genetic disorders.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.